These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15124766)

  • 41. Diffusion tensor tractography-based group mapping of the pyramidal tract in relapsing-remitting multiple sclerosis patients.
    Lin F; Yu C; Jiang T; Li K; Chan P
    AJNR Am J Neuroradiol; 2007 Feb; 28(2):278-82. PubMed ID: 17296994
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G; Dinacci D; Comerci M; Lavorgna L; Savettieri G; Quattrone A; Livrea P; Patti F; Morra VB; Servillo G; Orefice G; Paciello M; Prinster A; Coniglio G; Bonavita S; Di Costanzo A; Bellacosa A; Valentino P; Quarantelli M; Brunetti A; Salemi G; D'Amelio M; Simone I; Salvatore M; Bonavita V; Alfano B
    Mult Scler; 2009 Feb; 15(2):204-11. PubMed ID: 18987104
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MRI characteristics of patients with antiphospholipid syndrome and multiple sclerosis.
    Stosic M; Ambrus J; Garg N; Weinstock-Guttman B; Ramanathan M; Kalman B; Minagar A; Munschauer FE; Galey TM; Hussein S; Bakshi R; Zivadinov R
    J Neurol; 2010 Jan; 257(1):63-71. PubMed ID: 19633967
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gray matter atrophy in multiple sclerosis: a longitudinal study.
    Fisher E; Lee JC; Nakamura K; Rudick RA
    Ann Neurol; 2008 Sep; 64(3):255-65. PubMed ID: 18661561
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gray matter N-acetyl aspartate deficits in secondary progressive but not relapsing-remitting multiple sclerosis.
    Adalsteinsson E; Langer-Gould A; Homer RJ; Rao A; Sullivan EV; Lima CA; Pfefferbaum A; Atlas SW
    AJNR Am J Neuroradiol; 2003; 24(10):1941-5. PubMed ID: 14625214
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Longitudinal evaluation of clinically early relapsing-remitting multiple sclerosis with diffusion tensor imaging.
    Rashid W; Hadjiprocopis A; Davies G; Griffin C; Chard D; Tiberio M; Altmann D; Wheeler-Kingshott C; Tozer D; Thompson A; Miller DH
    J Neurol; 2008 Mar; 255(3):390-7. PubMed ID: 18350361
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diffusion tensor MR imaging evaluation of the corpus callosum of patients with multiple sclerosis.
    Rueda F; Hygino LC; Domingues RC; Vasconcelos CC; Papais-Alvarenga RM; Gasparetto EL
    Arq Neuropsiquiatr; 2008 Sep; 66(3A):449-53. PubMed ID: 18813697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fourier transform power spectrum is a potential measure of tissue alignment in standard MRI: A multiple sclerosis study.
    Sharma S; Zhang Y
    PLoS One; 2017; 12(4):e0175979. PubMed ID: 28414816
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Corpus callosal diffusivity predicts motor impairment in relapsing-remitting multiple sclerosis: a TBSS and tractography study.
    Kern KC; Sarcona J; Montag M; Giesser BS; Sicotte NL
    Neuroimage; 2011 Apr; 55(3):1169-77. PubMed ID: 21056674
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diffusion tensor imaging applications in multiple sclerosis patients using 3T magnetic resonance: a preliminary study.
    Testaverde L; Caporali L; Venditti E; Grillea G; Colonnese C
    Eur Radiol; 2012 May; 22(5):990-7. PubMed ID: 22160194
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Diffusion tensor analysis of pediatric multiple sclerosis and clinically isolated syndromes.
    Vishwas MS; Healy BC; Pienaar R; Gorman MP; Grant PE; Chitnis T
    AJNR Am J Neuroradiol; 2013 Feb; 34(2):417-23. PubMed ID: 22859275
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Non-Gaussian diffusion MRI of gray matter is associated with cognitive impairment in multiple sclerosis.
    Bester M; Jensen JH; Babb JS; Tabesh A; Miles L; Herbert J; Grossman RI; Inglese M
    Mult Scler; 2015 Jun; 21(7):935-44. PubMed ID: 25392318
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relapsing neuromyelitis optica and relapsing-remitting multiple sclerosis: differentiation at diffusion-tensor MR imaging of corpus callosum.
    Yu CS; Zhu CZ; Li KC; Xuan Y; Qin W; Sun H; Chan P
    Radiology; 2007 Jul; 244(1):249-56. PubMed ID: 17522347
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Secondary-progressive form of multiple sclerosis: MRI changes versus clinical status.
    Masek M; Vaneckova M; Krasensky J; Danes J; Havrdova E; Hrebikova T; Seidl Z
    Neuro Endocrinol Lett; 2008 Aug; 29(4):461-6. PubMed ID: 18766142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study.
    Rovaris M; Bozzali M; Iannucci G; Ghezzi A; Caputo D; Montanari E; Bertolotto A; Bergamaschi R; Capra R; Mancardi GL; Martinelli V; Comi G; Filippi M
    Arch Neurol; 2002 Sep; 59(9):1406-12. PubMed ID: 12223026
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Diffusion tensor imaging in multiple sclerosis: assessment of regional differences in the axial plane within normal-appearing cervical spinal cord.
    Hesseltine SM; Law M; Babb J; Rad M; Lopez S; Ge Y; Johnson G; Grossman RI
    AJNR Am J Neuroradiol; 2006; 27(6):1189-93. PubMed ID: 16775261
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evidence for early, non-lesional cerebellar damage in patients with multiple sclerosis: DTI measures correlate with disability, atrophy, and disease duration.
    Deppe M; Tabelow K; Krämer J; Tenberge JG; Schiffler P; Bittner S; Schwindt W; Zipp F; Wiendl H; Meuth SG
    Mult Scler; 2016 Jan; 22(1):73-84. PubMed ID: 25921041
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Disconnection as a mechanism for cognitive dysfunction in multiple sclerosis.
    Dineen RA; Vilisaar J; Hlinka J; Bradshaw CM; Morgan PS; Constantinescu CS; Auer DP
    Brain; 2009 Jan; 132(Pt 1):239-49. PubMed ID: 18953055
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebral atrophy and disability in relapsing-remitting and secondary progressive multiple sclerosis over four years.
    Turner B; Lin X; Calmon G; Roberts N; Blumhardt LD
    Mult Scler; 2003 Feb; 9(1):21-7. PubMed ID: 12617263
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Peak width of skeletonized mean diffusivity (PSMD) as marker of widespread white matter tissue damage in multiple sclerosis.
    Vinciguerra C; Giorgio A; Zhang J; Di Donato I; Stromillo ML; Tappa Brocci R; Federico A; Dotti MT; De Stefano N
    Mult Scler Relat Disord; 2019 Jan; 27():294-297. PubMed ID: 30448470
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.